We engineer the technology.
You write the future.
Heart Rhythm 2022: Product Highlights
Extraordinary technology requires an extraordinary mind to use it. Discover more compelling features and benefits of the products within Boston Scientific's heart rhythm management portfolio.
The power to target with greater confidence.
Local impedance measurements with DIRECTSENSE™ Technology provide a clear indication of subsurface temperature change, capturing valuable insights up to 4mm below the tissue surface with greater specificity than surface temperature monitoring.1
Power to transform and expand atrial fibrillation treatment options
Pioneering tissue-selective ablation. >2,000 patients successfully treated in Europe.*
CE Marked January 2021.
*Caution: Investigational device. Limited by Federal (or US) law to investigational use only. Not available for sale.
WATCHMAN FLXTM LAAC Device
Built on the most studied and implanted LAAC device in the world – WATCHMAN FLX™ is the leader in LAAC therapy. WATCHMAN FLX offers proven safety, unmatched procedural simplicity and excellent seal to help ensure optimal device performance.
Diagnostics & Services
LUX-Dx ICM System.
Combining clear signal quality, dual-stage algorithms and remote programming, the LUX-Dx ICM difference is clear from the moment of insertion.
Assess every heartbeat in an easy-to-read, data-rich report.
Power to set a new standard of care.
Proven & published. Over 100,000 patients protected.
Power to optimize programming without sacrificing longevity
Boston Scientific’s MultiSite Pacing converted 51% of non-responders to responders at 12 months with minimal impact to battery life.2
Remote Patient Management
Fast device checks. Efficient patient care.
The LATITUDE Consult system gives your team the ability to quickly conduct pacemaker and defibrillator device checks. There is no need to wait for a device expert to arrive on site.
Stay Up to Date
Receive emails on the latest news from Boston Scientific.
1. Garrott KE, Lehn L, Gams A, et al., Intra-lesion temperature rise and local impedance drop predictive of lesion growth on RF ablation catheter with mini electrodes. Abstract accepted to Heart Rhythm Society Annual Meeting, May 2020. Distributed with permission from the Heart Rhythm Society.
2. Saba S, et al. Safety and Effectiveness of Multi-Site Pacing in Initial Non-Responders to Conventional Cardiac Resynchronization Therapy. LBCT presented at: 2021 Heart Rhythm Society; July 2021; Boston, MA
**CE marked January 2021